These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 58458)

  • 1. Role of the murine major histocompatibility complex in the specificity of in vitro T-cell-mediated lympholysis against chemically-modified autologous lymphocytes.
    Shearer GM; Rehn TG; Schmitt-Verhulst AM
    Transplant Rev; 1976; 29():222-46. PubMed ID: 58458
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions.
    Peck AB; Alter BJ; Lindahl KF
    Transplant Rev; 1976; 29():189-221. PubMed ID: 58457
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR; Knight RA; Mitchison NA; Gorczynski RM; Maoz A
    Transplant Rev; 1976; 29():249-76. PubMed ID: 58459
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Rehn TG; Shearer GM; Koren HS; Inman JK
    J Exp Med; 1976 Jan; 143(1):127-42. PubMed ID: 53266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymus derived killer cells: specificity of function, and antigen recognition.
    Dennert G
    Transplant Rev; 1976; 29():59-88. PubMed ID: 58462
    [No Abstract]   [Full Text] [Related]  

  • 7. Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.
    Schmitt-Verhulst AM; Shearer GM
    J Exp Med; 1975 Oct; 142(4):914-27. PubMed ID: 52685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 9. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
    Wagner H; Röllinghoff M; Nossal GJ
    Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of T-cell mediated cytolysis.
    Henney CS
    Transplant Rev; 1973; 17(0):37-70. PubMed ID: 4135078
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of cell-mediated lympholysis for public and private H-2 determinants.
    Lindahl F; Peck AB; Bach FH
    Scand J Immunol; 1975 Sep; 4(5-6):541-53. PubMed ID: 52182
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex.
    Widmer MB; Alter BJ; Bach FH; Bach ML
    Nat New Biol; 1973 Apr; 242(121):239-41. PubMed ID: 4267212
    [No Abstract]   [Full Text] [Related]  

  • 13. Speculations on the role of major transplantation antigens in cell-mediated immunity against intracellular parasites.
    Zinkernagel RM
    Curr Top Microbiol Immunol; 1978; 82():113-38. PubMed ID: 83220
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of H-2 mutants as models for the study of T cell activation.
    McKenzie IF; Pang T; Blanden RV
    Immunol Rev; 1977; 35():179-230. PubMed ID: 70397
    [No Abstract]   [Full Text] [Related]  

  • 15. Origins and mechanisms of specificity in clonal selection.
    Edelman GM
    Soc Gen Physiol Ser; 1974; 29():1-38. PubMed ID: 4139761
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
    Brondz BD; Egorov IK
    Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
    [No Abstract]   [Full Text] [Related]  

  • 17. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 18. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.
    Zinkernagel RM; Doherty PC
    Nature; 1974 Apr; 248(5450):701-2. PubMed ID: 4133807
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuously proliferating allospecific T cells, lifespan and antigen receptors.
    Dennert G; Raschke W
    Eur J Immunol; 1977 Jun; 7(6):352-9. PubMed ID: 70355
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds.
    Rehn TG; Inman JK; Shearer GM
    J Exp Med; 1976 Oct; 144(4):1134-40. PubMed ID: 62013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.